Bitte machen Sie den PCOS-Diva-Symptomtest, bevor Sie mit dem 21-Tage-Programm beginnen, und ein weiteres Mal, sobald Sie ihn beendet haben. Dieser kleine Fragebogen soll Sie dabei unterstützen, Ihre Symptome zu erkennen und einzuschätzen, wie sie sich in nur 21 Tagen verbessern können. Sie werden sich nach den 3 Wochen so viel besser fühlen, dass Sie womöglich vergessen, wie schlecht es Ihnen anfangs ging. Die Vorher-nachher-Ergebnisse miteinander zu vergleichen, soll Ihnen beim Wahrnehmen der Veränderungen helfen.
Bewerten Sie auf einer Skala von 1 bis 5 Ihre derzeitigen PCOS-Symptome.
1 = Ich bemerke dieses Symptom nicht.
2 = Das Symptom ist ein geringes Problem. Ich bemerke es, aber es stört mich nicht sehr.
3 = Das Symptom ist ein mittleres Problem für mich. Es beeinflusst mein Leben, aber ich komme damit zurecht.
4 = Das Symptom stellt für mich ein ernsthaftes Problem dar. Ich kämpfe laufend damit.
5 = Das Symptom hat gravierende Auswirkungen. Ich komme kaum zurecht.
Datum: |
Symptom |
Akne 1 2 3 4 5 |
Blähungen 1 2 3 4 5 |
Reizbarkeit 1 2 3 4 5 |
Müdigkeit 1 2 3 4 5 |
Stimmungsschwankungen 1 2 3 4 5 |
Stress 1 2 3 4 5 |
Konzentrationsstörungen 1 2 3 4 5 |
schwache Libido 1 2 3 4 5 |
Gewichtszunahme 1 2 3 4 5 |
unregelmäßiger Monatszyklus 1 2 3 4 5 |
Blutzuckerschwankungen 1 2 3 4 5 |
Sonstiges ______________________ 1 2 3 4 5 |
Gesamt aus jeder Spalte |
Gesamtpunktzahl |
Gemeinnützige PCOS-Unternehmen:
PCOS Awareness Association (pcosaa.org)
PCOS Challenge (pcoschallenge.org)
Verity (verity-pcos.org.uk)
Experten, die Amy empfiehlt:
Viele dieser Experten finden Sie auch im PCOS-Diva-Podcast.
PCOS
Lara Briden, ND (LaraBriden.com)
Poppy Daniels, MD (DrPoppy.com)
Shawna Darou, ND (darouwellness.com)
Nancy Dunne, ND (pcosconsultations.com)
Felice Gersh, MD (felicelgershmd.com)
Dian Ginsberg, MD (womensspecialtyhealthcare.com)
Brooke Kalanic, ND (betterbydrbrooke.com)
Meaghan Kirschling, DC, APRN, RN, MS (oneagorahealth.com)
Karen Leggett, MD (drkarenleggett.com)
Carol Lourie, ND, LAc (carollourie.com)
Fiona McCulloch, ND (drfionand.com)
Margrit Mikulis, ND (livingnaturalinc.com)
Rebecca Murray, APRN, FNP, CDE (instituteofhormonalbalance.com)
Katherine Sherif, MD (hospitals.jefferson.edu/departments-and-services/womens-primary-care.html)
Kinderwunsch
Rashmi Kudesia, MD, MSc (houstonivf.net)
Victoria Maizes, MD (victoriamaizesmd.com)
Marc Perloe, MD (arcfertility.com)
Aimee Raupp (aimeeraupp.com)
Aumatma Shah, ND (draumatma.com)
Marc Sklar, DC (MarcSklar.com und Reproductive Wellness.com)
Schilddrüsenfunktion
Shannon Garrett, BS, RN, CNN (holisticthyroidcare.net)
Izabella Wentz, PharmD, FASCP (thyroidpharmacist.com)
Magdalena Wszelaki (hormonesbalance.com)
Angststörungen
Megan Buer (harmony-restored.com)
Trudy Scott, CN (everywomanover29.com)
Emotionsgesteuertes oder gestörtes Essverhalten
Stephanie Dodier, CCN (stephaniedodier.com)
Melissa McCreery, PhD, MA (toomuchonherplate.com)
Bücher in Amys Bücherschrank:
PCOS und Hormone
Schlank ohne Stress von Alan Christianson, NMD
8 Steps to Reverse Your PCOS von Fiona McCulloch, ND
Das Hashimoto-Programm von Izabella Wentz, PharmD, FASCP
Die Hormonkur von Sara Gottfried, MD
The Hormone Link von Margarita Ochoa Maya, MD
Integrative Women’s Health von Victoria Maizes, MD, und Tieraona
Low Dog, MD
Life Is Your Best Medicine von Tieraona Low Dog, MD
The Natural Diet Solution for PCOS and Infertility von Nancy Dunne, ND, und Bill Slater, M.B.A.
A Patient’s Guide to PCOS von Walter Futterweit, MD
PCOS von Samuel Thatcher, MD
The Period Repair Manual von Lara Briden, ND
The Ultimate PCOS Handbook von Colette Harris und Theresa Cheung
Denken wie eine PCOS-Diva
Beautiful You von Rosie Molinary
Begin with Yes von Paul S. Boynton
Lebe dein Leben, bevor es andere für dich tun von Gay Hendricks
Big Magic von Elizabeth Gilbert
Bonjour Happiness von Jamie Cat Callan
Ein Kurs im Abnehmen von Marianne Williamson
The Desire Map von Danielle LaPorte
Die Vier Versprechen von Don Miguel Ruiz
The Gift of an Ordinary Day von Katrina Kenison
Gifts of Imperfection von Brené Brown
Achte Dich selbst! von Patricia Spadaro
Nothing Changes Until You Do von Mike Robbins
A Philosopher’s Notes von Brian Johnson
The Rhythm of Life von Matthew Kelly
Morgen fange ich an … warum nicht heute? von Steven Pressfield
Gesundheit für Körper und Seele von Louise Hay
Leben wie eine PCOS-Diva
Magic Cleaning von Marie Kondo
Tapping: Leben ohne Stress von Nick Ortner
The Tapping Solution for Weight Loss and Body Confidence von Jessica Ortner
Einen Arzt finden
American Association of Naturopathic Physicians (naturopathic.org)
The Institute of Functional Medicine (ifm.org)
1 »Infertility FAQs«, Centers for Disease Control and Prevention, 30. März 2017, https://www.cdc.gov/reproductivehealth/infertility/index.htm.
2 Susan Sirmans und Kirsten Pate, »Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome«, Clinical Epidemiology (2013): 1, doi:10.2147/clep.s37559.
3 »PCOS Support Groups«, PCOS Foundation, http://pcosfoundation.org/support-groups.
4 Samuel S. Thatcher, PCOS: The Hidden Epidemic (Indianapolis: Perspectives Press, 2000), 320.
5 »Diabetes Home«, Centers for Disease Control and Prevention, 11. Oktober 2016, https://www.cdc.gov/diabetes/library/spotlights/pcos.html.
6 »Polycystic Ovary Syndrome«, womenshealth.gov, 26. Juli 2017, https://www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome.
7 Samuel S. Thatcher, »PCOS 101«, http://memberfiles.freewebs.com/26/91/38059126/documents/2005%20HS%20and%20PCOS%20Thatcher%20MD.pdf.
8 Stephenson et al., »Luteal Start Vaginal Micronized Progesterone«; Pedro Acien et al., »Insulin, Androgens, and Obesity in Women with and Without Polycystic Ovary Syndrome: A Heterogeneous Group of Disorders«, Fertility and Sterility 72/1 (Juli 1999): 32–40, doi:10.1016/s0015-0282(99)00184-3; Nancy Dunne und Bill Slater, The Natural Diet Solution for PCOS and Infertility: How to Manage Polycystic Ovary Syndrome Naturally (Seattle: Health Solutions Press, 2005), 28.
9 Charles J. Glueck et al., »Obesity and Extreme Obesity, Manifest by Ages 20–24 Years, Continuing Through 32–41 Years in Women, Should Alert Physicians to the Diagnostic Likelihood of Polycystic Ovary Syndrome as a Reversible Underlying Endocrinopathy«, European Journal of Obstetrics & Gynecology and Reproductive Biology 122/2 (1. Oktober 2005): 206–12, doi:10.1016/j.ejogrb.2005.03.010; H. J. Teede et al., »Body Mass Index as a Predictor of Polycystic Ovary Syndrome Risk: Results of a Longitudinal Cohort Study«, The Endocrine Society’s 92nd Annual Meeting, 19.–22. Juni 2010, San Diego, P2-414, 19. Juni 2010, http://dx.doi.org/10.1210/endo-meetings.2010.PART2.P9.P2-414.
10 Walter Futterweit und George Ryan, A Patient’s Guide to PCOS: Understanding and Reversing Polycystic Ovarian Syndrome (New York: Holt, 2006), 19.
11 Thatcher, PCOS, 12.
12 Futterweit und Ryan, A Patient’s Guide to PCOS, 17.
13 Amanda A. Deeks, Melanie E. Gibson-Helm und Helena J. Teede, »Anxiety and Depression in Polycystic Ovary Syndrome: A Comprehensive Investigation«, Fertility and Sterility 93/7 (1. Februar 2010): 2421–23, doi:10.1016/j.fertnstert.2009.09.018; Sudhindra Mohan Bhattacharya und Ayan Jha, »Prevalence and Risk of Depressive Disorders in Women with Polycystic Ovary Syndrome (PCOS)«, Fertility and Sterility 94/1 (6. November 2009): 357–59, doi:10.1016/j.fertnstert.2009.09.025; Varvara Laggari et al., »Anxiety and Depression in Adolescents with Polycystic Ovary Syndrome and Mayer-Rokitansky-Kuster-Hauser Syndrome«, Journal of Psychosomatic Obstetrics & Gynecology 30/2 (2009): 83–88, doi:10.1080/01674820802546204.
14 Tsilchorozidou, Honour und Conway, »Altered Cortisol Metabolism in Polycystic Ovary Syndrome«; Shabir et al., »Morning Plasma Cortisol Is Low«; Pasquali und Gambineri, »Cortisol and the Polycystic Ovary Syndrome«.
15 Dominik Rachoń und Helena Teede, »Ovarian Function and Obesity–Interrelationship, Impact on Women’s Reproductive Lifespan and Treatment Options«, Molecular and Cellular Endocrinology 316/2 (25. März 2010): 172–79, doi:10.1016/j.mce.2009.09.026; Mitlitsky, »7 Common Symptoms Associated with Low Progesterone«.
16 Futterweit und Ryan, A Patient’s Guide to PCOS, 11.
17 Futterweit und Ryan, A Patient’s Guide to PCOS, 21.
18 Futterweit und Ryan, A Patient’s Guide to PCOS, 20.
19 Futterweit und Ryan, A Patient’s Guide to PCOS, 15.
20 Futterweit und Ryan, A Patient’s Guide to PCOS, 19.
21 Richard S. Legro, V. Daniel Castracane und Robert P. Kauffman, »Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls«, Obstetrical & Gynecological Survey 59/2 (1. Februar 2004): 141–54, doi:10.1097/01.ogx.0000109523.25076.e2.
22 »Prediabetes and Insulin Resistance«, National Institute of Diabetes and Digestive and Kidney Diseases, 1. August 2009, https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance.
23 Thozhukat, Sathyapalan und Stephen L. Atkin, »Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity«, Mediators of Inflammation, 18. März 2010, https://www.hindawi.com/journals/mi/2010/758656/; A. Dunaif et al., »Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome«, Diabetes 38/9 (September 1989): 1165–74, doi:10.2337/diabetes.38.9.1165.
24 Adeola A. Adeniji et al., »Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women with and Without Polycystic Ovary Syndrome«, Journal of Women’s Health 25/6 (1. Januar 1970): 638–45, doi:10.1089/jwh.2015.5418; R. Jeffrey Chang et al., »Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease«, Journal of Clinical Endocrinology & Metabolism 57/2 (August 1983): 356–59, doi:10.1210/jcem-57-2-356.
25 Richard S. Legro, »Hyperandrogenism and Hyperinsulinemia«, Global Library of Women’s Medicine, 2008, doi:10.3843/glowm.10303.
26 L. Pal, Polycystic Ovary Syndrome: Current and Emerging Concepts (New York: Springer, 2014); Bulent O. Yildiz et al., »Stability of Adrenocortical Steroidogenesis over Time in Healthy Women and Women with Polycystic Ovary Syndrome«, Journal of Clinical Endocrinology & Metabolism 89/11 (November 2004): 5558–62, doi:10.1210/jc.2004-0934.
27 Fionna McCulloch, »PCOS: Treating Adrenal Androgen Excess«, Naturopathic Doctor News and Review, 30. Januar 2015, http://ndnr.com/womens-health/pcos-treating-adrenal-androgen-excess/.
28 Yildiz et al., »Stability of Adrenocortical Steroidogenesis«.
29 Lara Briden, »Causes of Androgen Excess in Women«, Lara Briden’s Healthy Hormone Blog, 25. Mai 2017, http://www.larabriden.com/causes-androgen-excess-in-women/.
30 Tasoula Tsilchorozidou, John W. Honour und Gerard S. Conway, »Altered Cortisol Metabolism in Polycystic Ovary Syndrome: Insulin Enhances 5-Reduction but Not the Elevated Adrenal Steroid Production Rates«, Journal of Clinical Endocrinology & Metabolism 88/12 (26. April 2011): 5907–913, doi:10.1210/jc.2003–030240; Iram Shabir et al., »Morning Plasma Cortisol Is Low Among Obese Women with Polycystic Ovary Syndrome«, Gyneco-logical Endocrinology 29/12 (Dezember 2013): 1045–047, doi:10.3109/09513590.2013.82 9449; Renato Pasquali und Alessandra Gambineri, »Cortisol and the Polycystic Ovary Syndrome«, Medscape, 2012, https://www.medscape.com/viewarticle/773775.
31 Mary D. Stephenson et al., »Luteal Start Vaginal Micronized Progesterone Improves Pregnancy Success in Women with Recurrent Pregnancy Loss«, Fertility and Sterility 107/3 (März 2017), doi:10.1016/j.fertnstert.2016.11.029.
32 »Progestin (Oral Route, Parenteral Route, Vaginal Route) Side Effects«, Mayo Clinic, 1. März 2017, http://www.mayoclinic.org/drugs-supplements/progestin-oral-route-parenteral-route-vaginal-route/side-effects/DRG-20069443.
33 Chris Mitlitsky, »7 Common Symptoms Associated with Low Progesterone«, Dr. Tami, 26. Juni 2015, https://www.drtami.com/7-common-symptoms-associated-with-low-progesterone/.
34 Kris Poppe, Brigitte Velkeniers und Daniel Glinoer, »Thyroid Disease and Female Reproduction«, Clinical Endocrinology 66/3 (März 2007): 309–21, doi:10.1111/j.1365-2265.2007.02752.x.
35 Fiona McCulloch, 8 Steps to Reverse Your PCOS: A Proven Program to Reset Your Hormones, Repair Your Metabolism and Restore Your Fertility (Austin, TX: Greenleaf Book Group, 2016), 66–69.
36 »The Difference Between Hypothyroidism and Hyperthyroidism«, Piedmont Healthcare, aufgerufen am 24. Oktober 2017, https://www.piedmont.org/living-better/the-difference-between-hypothyroidism-and-hyperthyroidism.
37 Felice Gersh, »PCOS Inflammation: Transform from Inflamed to Tamed«, PCOS Diva, 23. Mai 2015, https://pcosdiva.com/2015/05/pcos-and-inflammation-transform-from-inflamed-to-tamed/.
38 Hector F. Escobar-Morreale, Manuel Luque-Ramirez und Frank Gonzalez, »Circulating Inflammatory Markers in Polycystic Ovary Syndrome: A Systematic Review and Metaanalysis«, Fertility and Sterility 95/3 (1. März 2011), doi:10.1016/j.fertnstert.2010.11.036.
39 S. L. Kristensen et al., »A Very Large Proportion of Young Danish Women Have Polycystic Ovaries: Is a Revision of the Rotterdam Criteria Needed?« Human Reproduction 25/12 (Dezember 2010): 3117–22, doi:10.1093/humrep/deq273; Richard S. Legro und Jerome F. Strauss, »Molecular Progress in Infertility: Polycystic Ovary Syndrome«, Fertility and Sterility 78/3 (29. August 2002): 569–76, doi:10.1016/s0015-0282(02)03275-2.
40 Futterweit und Ryan, A Patient’s Guide to PCOS, 11.
41 Evanthia Diamanti-Kandarakis, Charikleia Christakou und Evangelos Marinakis, »Phenotypes and Environmental Factors: Their Influence in PCOS«, Current Pharmaceutical Design 18/3 (2012): 270–82, doi:10.2174/138161212799040457.
42 Angela Best Boss, Evelina Weidman Sterling und Jerald S. Goldstein, Living with PCOS: Polycystic Ovary Syndrome (Omaha: Addicus Books, 2009), 3.
43 R. Zawadaki und M. Dockerty, »Diagnostic Criteria for Polycystic Ovarian Syndrome: Towards a Rational Approach«, in A. Dunaif et al., eds., Current Issues in Endocrinology and Metabolism: Polycystic Ovarian Syndrome (Boston: Blackwell Scientific, 1992), 337.
44 R. E. Roach et al., »The Risk of Heart Attack and Stroke in Women Using Birth Control Pills«, Cochrane, 27. August 2015, http://www.cochrane.org/CD011054/FERTILREG_risk-heart-attack-and-stroke-women-using-birth-control-pills.
45 George Mastorakos et al., »Effects of Two Forms of Combined Oral Contraceptives on Carbohydrate Metabolism in Adolescents with Polycystic Ovary Syndrome«, Fertility and Sterility 85/2 (2. Februar 2006): 420–27, doi:10.1016/j.fertnstert.2005.07.1306; Abbey B. Berenson et al., »Effect of Injectable and Oral Contraceptives on Glucose and Insulin Levels«, Obstetrics & Gynecology 117/1 (Januar 2011): 41–47, doi:10.1097/aog.0b013e-318202ac23; T. Piltonen et al., »Oral, Transdermal and Vaginal Combined Contraceptives Induce an Increase in Markers of Chronic Inflammation and Impair Insulin Sensitivity in Young Healthy Normal-Weight Women: A Randomized Study«, Human Reproduction 27/10 (18. Juli 2012): 3046–56, doi:10.1093/humrep/des225.
46 I. F. Godsland et al., »Insulin Resistance, Secretion, and Metabolism in Users of Oral Contraceptives«, Journal of Clinical Endocrinology & Metabolism 74/1 (1. Januar, 1992): 64–70, doi:10.1210/jc.74.1.64.
47 Gilbert G. Donders, Gert Bellen und Werner Mendling, »Management of Recurrent Vulvo-Vaginal Candidosis as a Chronic Illness«, Gynecologic and Obstetric Investigation 70/4 (16. Oktober 2010): 306–21, doi:10.1159/000314022; G. Cheng, K. M. Yeater und L. L. Hoyer, »Cellular and Molecular Biology of Candida albicans Estrogen Response«, Eukaryotic Cell 5/1 (1. Januar 2006): 180–91, doi:10.1128/ec.5.1.180-191.2006.
48 »National Institutes of Health Evidence-based Methodology Workshop on Polycystic Ovary Syndrome, Executive Summary«, National Institutes of Health, 3. Dezember 2012, https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf.
49 David S. H. Bell, »Metformin-Induced Vitamin B12 Deficiency Presenting as a Peripheral Neuropathy«, Southern Medical Journal 103/3 (März 2010): 265–67, doi:10.1097/smj.0b013e3181ce0e4d.
50 R. Jeffrey Chang, »Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease«, Journal of Clinical Endocrinology & Metabolism 57/2 (1. August 1983): 356–59, doi:10.1210/jcem-57–2–356; L. Ibanez et al., »Sensitization to Insulin Induces Ovulation in Nonobese Adolescents with Anovulatory Hyperandrogenism«, Journal of Clinical Endocrinology & Metabolism 86/8 (1. August 2001): 3595–98, doi:10.1210/jc.86.8.3595.
51 I. I. Muderris, F. Bayram und M. Guven, »Treatment of Hirsutism with Lowest-Dose Flutamide (62.5 mg/day)«, Gynecological Endocrinology 14/1 (2000): 38–41, doi:10.3109/09513590009167658.
52 Enrico Carmina und Rogerio A. Lobo, »A Comparison of the Relative Efficacy of Anti-androgens for the Treatment of Acne in Hyperandrogenic Women«, Clinical Endocrinology 57/2 (2. August 2002): 231–34, doi:10.1046/j.1365-2265.2002.01594.x.
53 Leonello Cusan et al., »Comparison of Flutamide and Spironolactone in the Treatment of Hirsutism«, Obstetrical & Gynecological Survey 49/7 (6. Mai 2016): 481–83, doi:10.1097/00006254-199407000-00020.
54 »Flutamide (oral)«, University of Michigan Health Services, 15. Dezember 2010, http://www.uofmhealth.org/node/663457.
55 Kathleen M. Hoeger, »Obesity and Lifestyle Management in Polycystic Ovary Syndrome«, Clinical Obstetrics and Gynecology 50/1 (Mai 2007): 277–94, doi:10.1097/grf.0b013e31802f54c8; Lisa J. Moran et al., »Effects of Lifestyle Modification in Polycystic Ovarian Syndrome«, Reproductive BioMedicine Online 12/5 (Mai 2006): 569–78, doi:10.1016/s1472-6483(10)61182-0; W. C. Knowler et al., »Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin«, New England Journal of Medicine 346/6 (7. Februar 2002): 393–403, doi:10.1056/nejmoa012512; Thomas Tang et al., »Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Double-Blind Multicentre Study«, Obstetrical & Gynecological Survey 61/2 (31. September 2005): 108–9, doi:10.1097/01. ogx.0000197800.07214.dc; Robert Norman et al. [Davies, Lord, Moran], »The Role of Lifestyle Modification in Polycystic Ovary Syndrome«, Trends in Endocrinology and Metabolism 13/6 (1. August 2002): 251–57, https://doi.org/10.1016/S1043-2760(02)00612-4; Kathleen M. Hoeger, »Role of Lifestyle Modification in the Management of Polycystic Ovary Syndrome«, Best Practice & Research, Clinical Endocrinology & Metabolism 20/2 (Juni 2006): 293–310, doi:10.1016/j.beem.2006.03.008.
56 Colette Harris und Theresa Cheung, The Ultimate PCOS Handbook: Lose Weight, Boost Fertility, Clear Skin and Restore Self-Esteem (San Francisco: Conari, 2012), 28.
57 Lisa J. Moran et al., »Treatment of Obesity in Polycystic Ovary Syndrome: A Position Statement of the Androgen Excess and Polycystic Ovary Syndrome Society«, Fertility and Sterility 92/6 (2009): 1966–82, doi:10.1016/j.fertnstert.2008.09.018; Robert Ross et al., »Reduction in Obesity and Related Comorbid Conditions After Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men«, Annals of Internal Medicine 133/2 (18. Juli 2000): 92, doi:10.7326/0003-4819-133-2-200007180-00008; C. L. Harrison et al., »Exercise Therapy in Polycystic Ovary Syndrome: A Systematic Review«, Human Reproduction Update 17/2 (10. September 2010): 171–83, doi:10.1093/humupd/dmq045.
58 Thatcher, »PCOS«, 101.
59 Kristen L. Knutson, »Impact of Sleep and Sleep Loss on Glucose Homeostasis and Appetite Regulation«, Sleep Medicine Clinics 2/2 (Juni 2007): 187–97, doi:10.1016/j.jsmc.2007.03.004; »Sleep and Disease Risk«, Healthy Sleep, Division of Sleep Medicine at Harvard Medical School, 18. Dezember 2007, http://healthysleep.med.harvard.edu/healthy/matters/consequences/sleep-and-disease-risk.
60 K. F. Michelmore, A. H. Balen und D. B. Dunger, »Polycystic Ovaries and Eating Disorders: Are They Related?« Human Reproduction 16/4 (1. April 2001): 765–69, doi:10.1093/humrep/16.4.765.
61 »Factors That May Contribute to Eating Disorders«, National Eating Disorders Association, aufgerufen am 25. Oktober 2017, https://www.nationaleatingdisorders.org/factors-may-contribute-eating-disorders.
62 M. Nathaniel Mead, »Nutrigenomics: The Genome–Food Interface«, Environmental Health Perspectives 115/12 (Dezember 2007), doi:10.1289/ehp.115-a582.
63 John M. Berardi, »Nutrigenomics: This Research Changes Everything«, Precision Nutrition, 1. Mai 2014, http://www.precisionnutrition.com/nutrigenomics-research.
64 Jeanelle Boyer und Rui Hai Liu, »Apple Phytochemicals and Their Health Benefits«, Nutrition Journal 3/1 (12. Mai 2004), doi:10.1186/1475-2891-3-5.
65 »Avocados«, The World’s Healthiest Foods, 23. Mai 2017, http://www.whfoods.com/genpage.php?tname=foodspice&dbid=5.
66 Tsuyoshi Goto et al., »Tiliroside, a Glycosidic Flavonoid, Ameliorates Obesity-Induced Metabolic Disorders via Activation of Adiponectin Signaling Followed by Enhancement of Fatty Acid Oxidation in Liver and Skeletal Muscle in Obese–Diabetic Mice«, Journal of Nutritional Biochemistry 23/7 (Juli 2012): 768–76, doi:10.1016/j.jnutbio.2011.04.001; Cetin Cekic und Mustafa Ozgen, »Comparison of Antioxidant Capacity and Phytochemical Properties of Wild and Cultivated Red Raspberries (Rubus idaeus L.)«, Journal of Food Composition and Analysis 23/6 (September 2010): 540–44, doi:10.1016/j.jfca.2009.07.002; Camille S. Bowen-Forbes, Yanjun Zhang und Muraleedharan G. Nair, »Anthocyanin Content, Antioxidant, Anti-Inflammatory and Anticancer Properties of Blackberry and Raspberry Fruits«, Journal of Food Composition and Analysis 23/6 (September 2010): 554–60, doi:10.1016/j.jfca.2009.08.012.
67 Chie Morimoto et al., »Anti-obese Action of Raspberry Ketone«, Life Sciences 77/2 (Mai 2005): 194–204, doi:10.1016/j.lfs.2004.12.029.
68 M. Kazemzadeh et al., »Effect of Brown Rice Consumption on Inflammatory Marker and Cardiovascular Risk Factors Among Overweight and Obese Non-menopausal Female Adults«, International Journal of Preventive Medicine 5/4 (April 2014): 478–88, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018597/.
69 »Manganese«, University of Maryland Medical Center, 31. Mai 2013, http://www.umm.edu/health/medical/altmed/supplement/manganese.
70 Jeff G. Wang et al., »The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: A Pilot Study«, Fertility and Sterility 88/1 (Juli 2007): 240–43, doi:10.1016/j.fertnstert.2006.11.082.
71 Daniel H. Kort und Roger A. Lobo, »Preliminary Evidence that Cinnamon Improves Menstrual Cyclicity in Women with Polycystic Ovary Syndrome«, Obstetrical & Gynecological Survey 70/2 (November 2014): 94–95, doi:10.1097/01.ogx.0000461902.16853.84.
72 David L. Katz, Kim Doughty und Ather Ali, »Cocoa and Chocolate in Human Health and Disease«, Antioxidants & Redox Signaling 15/10 (15. November 2011): 2779–811, doi:10.1089/ars.2010.3697.
73 Joseph Nordqvist, »Chocolate: Health Benefits, Facts, and Research«, Medical News Today, 1. Juni 2016, https://www.medicalnewstoday.com/articles/270272.php.
74 Megan Ware, »Magnesium: Health Benefits, Sources, and Risks«, Medical News Today, 25. September 2017, https://www.medicalnewstoday.com/articles/286839.php.
75 Bhardwaj Pooja und Khanna Deepa, »Green Tea Catechins: Defensive Role in Cardiovascular Disorders«, Chinese Journal of Natural Medicines 11/4 (Juli 2013): 345–53, doi:10.3724/sp.j.1009.2013.00345; Yoshihiro Kokubo et al., »The Impact of Green Tea and Coffee Consumption on the Reduced Risk of Stroke Incidence in Japanese Population«, Stroke 44 (März 2013): 1369–74, doi.org/10.1161/STROKEAHA.111.677500.
76 »Health Benefits of Green Tea«, WebMD, 13. September 2013, https://www.webmd.com/food-recipes/features/health-benefits-of-green-tea#1.
77 Katherine M. Phillips, Monica H. Carlsen und Rune Blomhoff, »Total Antioxidant Content of Alternatives to Refined Sugar«, Journal of the American Dietetic Association 109/1 (Januar 2009): 64–71, doi:10.1016/j.jada.2008.10.014.
78 Barry Sears und Mary Perry, »The Role of Fatty Acids in Insulin Resistance«, Lipids in Health and Disease 14/1 (29. September 2015), doi:10.1186/s12944-015-0123-1.
79 Julie-Anne Nazare et al., »Modulation of the Postprandial Phase by β-Glucan in Overweight Subjects: Effects on Glucose and Insulin Kinetics«, Molecular Nutrition & Food Research 53/3 (März 2009): 361–69, doi:10.1002/mnfr.200800023; A. L. Jenkins et al., »Depression of the Glycemic Index by High Levels of β-Glucan Fiber in Two Functional Foods Tested in Type 2 Diabetes«, European Journal of Clinical Nutrition 56/7 (Juli 2002): 622–28, doi:10.1038/sj.ejcn.1601367; N. Tapola et al., »Glycemic Responses of Oat Bran Products in Type 2 Diabetic Patients«, Nutrition, Metabolism and Cardiovascular Diseases 15/4 (August 2005): 255–61, doi:10.1016/j.numecd.2004.09.003.
80 »NIH Lactose Intolerance Conference-Panel Statement«, National Institutes of Health, 24. Februar 2010, https://consensus.nih.gov/2010/lactosestatement.htm.
81 G. Kristjansson, P. Venge und R. Hallgren, »Mucosal Reactivity to Cow’s Milk Protein in Coeliac Disease«, Clinical & Experimental Immunology 147/3 (März 2007): 449–55, doi:10.1111/j.1365-2249.2007.03298.x; Amy Myers, »The Dangers of Dairy«, Amy Myers MD, 18. Juli 2017, https://www.amymyersmd.com/2013/04/the-dangers-of-dairy/.
82 Izabella Wentz, »What Are Goitrogens and Do They Matter with Hashimoto’s?« Dr. Izabella Wentz, Pharm D, 7. August 2017, https://thyroidpharmacist.com/articles/what-are-goitrogens-and-do-they-matter-with-hashimotos.
83 Adrienne R. Barnosky et al., »Intermittent Fasting vs. Daily Calorie Restriction for Type 2 Diabetes Prevention: A Review of Human Findings«, Translational Research 164/4 (Oktober 2014): 302–11, doi:10.1016/j.trsl.2014.05.013.
84 J. B. Johnson et al., »Alternate Day Calorie Restriction Improves Clinical Findings and Reduces Markers of Oxidative Stress and Inflammation in Overweight Adults with Moderate Asthma«, Free Radical Biology and Medicine, 1. November 2007, doi:10.1016/j.freeradbiomed.2006.12.005.
85 Valter D. Longo und Mark P. Mattson, »Fasting: Molecular Mechanisms and Clinical Applications«, Cell Metabolism 19/2 (4. Januar 2016): 181–92, doi:10.1016/j.cmet.2013.12.008; J. Lee, K. B. Seroogy und M. P. Mattson, »Dietary Restriction Enhances Neurogenesis and Up-regulates Neurotrophin Expression in the Hippocampus of Adult Mice«, Journal of Neurochemistry 81 (21. Januar 2002): 57–59, doi:10.1046/j.1471–4159.81.s1.19_4.x; Jaewon Lee et al., »Dietary Restriction Increases the Number of Newly Generated Neural Cells, and Induces BDNF Expression, in the Dentate Gyrus of Rats«, Journal of Molecular Neuroscience 15/2 (Oktober 2000): 99–108, doi:10.1385/jmn:15:2:99.
86 »How Much Is Too Much?« Sugar Science, UCSF, 18. Dezember 2014, http://sugarscience.ucsf.edu/the-growing-concern-of-overconsumption/.
87 Paul Grant, »Spearmint Herbal Tea Has Significant Anti-androgen Effects in Polycystic Ovarian Syndrome: A Randomized Controlled Trial«, Phytotherapy Research, Februar 2010, doi:10.1002/ptr.2900.
88 C. S. Johnston, C. M. Kim und A. J. Buller, »Vinegar Improves Insulin Sensitivity to a High-Carbohydrate Meal in Subjects with Insulin Resistance or Type 2 Diabetes«, Diabetes Care 27/1 (Januar 2004): 281–82, doi:10.2337/diacare.27.1.281.
89 Arjuna B. Medagama, »The Glycaemic Outcomes of Cinnamon: A Review of the Experimental Evidence and Clinical Trials«, Nutrition Journal 14/1 (16. Oktober 2015), doi:10.1186/s12937-015-0098-9.
90 Shiqi Zhang et al., »Capsaicin Reduces Blood Glucose by Increasing Insulin Levels and Glycogen Content Better Than Capsiate in Streptozotocin-Induced Diabetic Rats«, Journal of Agricultural and Food Chemistry 65/11 (10. März 2017): 2323–330, doi:10.1021/acs.jafc.7b00132.
91 Sarah Bleich et al., »Artificial Sweeteners«, The Nutrition Source, 29. Januar 2016, https://www.hsph.harvard.edu/nutritionsource/healthy-drinks/artificial-sweeteners/.
92 J. A. Nettleton et al., »Diet Soda Intake and Risk of Incident Metabolic Syndrome and Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA)«, Diabetes Care 32/4 (16. Januar 2009): 688–94, doi:10.2337/dc08-1799.
93 Sharon P. G. Fowler, Ken Williams und Helen P. Hazuda, »Diet Soda Intake Is Associated with Long-Term Increases in Waist Circumference in a Biethnic Cohort of Older Adults: The San Antonio Longitudinal Study of Aging«, Journal of the American Geriatrics Society 63/4 (17. März 2015): 708–15, doi:10.1111/jgs.13376.
94 »Hold the Diet Soda? Sweetened Drinks Linked to Depression, Coffee Tied to Lower Risk«, American Academy of Neurology, 8. Januar 2013, https://www.aan.com/PressRoom/home/PressRelease/1128.
95 »Study: Cola Linked to Lower Bone Density in Women«, Tufts University E-News, 20. Oktober 2006, http://enews.tufts.edu/stories/22/2006/10/20/StudyColaLinkedToLowerBoneDensityInWomen.
96 Beata Banaszewska et al., »Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial«, The Journal of Clinical Endocrinology & Metabolism 101/11 (18. Oktober 2016): 4322–328, doi:10.1210/jc.2016-1858.
97 Shin Nishiumi et al., »Green and Black Tea Suppress Hyperglycemia and Insulin Resistance by Retaining the Expression of Glucose Transporter 4 in Muscle of High-Fat Diet-Fed C57BL/6J Mice«, Journal of Agricultural and Food Chemistry 58/24 (24. November 2010): 12916–2923, doi:10.1021/jf102840w; K. Liu et al., »Effect of Green Tea on Glucose Control and Insulin Sensitivity: A Meta-Analysis of 17 Randomized Controlled Trials«, American Journal of Clinical Nutrition 98/2 (26. Juni 2013): 340–48, doi:10.3945 / ajcn.112.052746.
98 Natalia De Las Heras et al., »Molecular Factors Involved in the Hypolipidemic-and Insulin-Sensitizing Effects of a Ginger (Zingiber officinale Roscoe) Extract in Rats Fed a High-Fat Diet«, Applied Physiology, Nutrition, and Metabolism 42/2 (2. November 2016): 209–15, doi:10.1139/apnm-2016-0374.
99 Roya Navekar et al., »Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases«, Journal of the American College of Nutrition 36/4 (Mai–Juni, 2017): 261–67, doi:10.1080/07315724.2016.1267597.
100 Paul Grant und Shamin Ramasamy, »An Update on Plant Derived Anti-Androgens«, International Journal of Endocrinology and Metabolism 10/2 (2012): 497–502, doi:10.5812/ ijem.3644.
101 A. C. Nobre, A. Rao und G. N. Owen, »L-theanine, a Natural Constituent in Tea, and Its Effect on Mental State«, Asia Pacific Journal of Clinical Nutrition 17/S1 (2008): 168, https://www.ncbi.nlm.nih.gov/pubmed/18296328.
102 Catharine Paddock, »Does a Cup of Tea Reduce Stress?« Medical News Today, 14. August 2009, https://www.medicalnewstoday.com/articles/160668.php.
103 D. Heber et al., »Green Tea, Black Tea, and Oolong Tea Polyphenols Reduce Visceral Fat and Inflammation in Mice Fed High-Fat, High-Sucrose Obesogenic Diets«, Journal of Nutrition 144/9 (September 2014): 1385–93, doi:10.3945/jn.114.191007.
104 Ellen Grant, »Polycystic Ovarian Syndrome: The Metabolic Syndrome Comes to Gynaecology«, The BMJ 317/7154 (1. August 1998): 329–32, doi:10.1136/bmj.317.7154.329.
105 M. Ramos et al., »Low Folate Status Is Associated with Impaired Cognitive Function and Dementia in the Sacramento Area Latino Study on Aging«, American Journal of Clinical Nutrition 82/6, 1346–52, https://www.ncbi.nlm.nih.gov/pubmed/16332669.
106 S. Gilbody, S. Lewis und T. Lightfoot, »Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE Review«, American Journal of Epidemiology 165/1 (30. Oktober 2006): 1–13, doi:10.1093/aje/kwj347.
107 J. Azimova et al., »Effects of MTHFR Gene Polymorphism on the Clinical and Electrophysiological Characteristics of Migraine«, BMC Neurology 13/103 (5. August 2013), doi:10.1186/1471-2377-13-103.
108 Aliza H. Stark, Michael A. Crawford und Ram Reifen, »Update on Alpha-Linolenic Acid«, Nutrition Reviews 66/6 (1. Juni 2008): 326–32, doi:10.1111/j.1753-4887.2008.00040.x.
109 Sriramoju M. Kumar et al., »Molecular Level Interaction of the Human Acidic Fibroblast Growth Factor with the Antiangiogenic Agent Inositol Hexaphosphate«, Biochemistry 49/50 (21. Dezember 2010): 10756–64, doi:10.1021/bi101318m; Christiaan B. Brink et al., »Effects of Myo-inositol Versus Fluoxetine and Imipramine Pretreatments on Serotonin 5HT2A and Muscarinic Acetylcholine Receptors in Human Neuroblastoma Cells«, Metabolic Brain Disease 19/1–2 (Juni 2004): 51–70, doi:10.1023/b:mebr.0000027417.74156.5f.
110 E. Papaleo et al., »Myo-inositol in Patients with Polycystic Ovary Syndrome: A Novel Method for Ovulation Induction«, Gynecological Endocrinology 23/12 (10. Oktober 2007): 700–703, doi:10.1080/09513590701672405.
111 Martino M Zacche et al., »Efficacy of Myo-inositol in the Treatment of Cutaneous Disorders in Young Women with Polycystic Ovary Syndrome«, Gynecological Endocrinology 25/8 (August 2009): 508–13, doi:10.1080/09513590903015544.
112 Nicolas Galazis, Myria Galazi und William Atiomo, »D-chiro-inositol and Its Significance in Polycystic Ovary Syndrome: A Systematic Review«, Gynecological Endocrinology 27/4 (10. Dezember 2010): 256–62, doi:10.3109/09513590.2010.538099.
113 Deepika Garg und Reshef Tal, »Inositol Treatment and ART Outcomes in Women with PCOS«, International Journal of Endocrinology (4. Oktober 2016): 1–9, doi:10.1155/2016/1979654.
114 John E. Nestler et al., »Ovulatory and Metabolic Effects of D-chiro-inositol in the Polycystic Ovary Syndrome«, Obstetrical & Gynecological Survey 54/9 (29. April 1999): 573–74, doi:10.1097/00006254-199909000-00018.
115 Maria J. Iuorno et al., »Effects of D-chiro-inositol in Lean Women with the Polycystic Ovary Syndrome«, Endocrine Practice 8/6 (November–Dezember 2002): 417–23, doi:10.4158/ep.8.6.417.
116 S. Colazingari et al., »The Combined Therapy Myo-inositol plus D-chiro-inositol, Rather Than D-chiro-inositol, Is Able to Improve IVF Outcomes: Results from a Randomized Controlled Trial«, Archives of Gynecology and Obstetrics 288/6 (Dezember 2013): 1405– 11, doi:10.1007/s00404-013-2855-3, https://www.ncbi.nlm.nih.gov/pubmed/23708322.
117 E. Wehr et al., »Association of Hypovitaminosis D with Metabolic Disturbances in Polycystic Ovary Syndrome«, European Journal of Endocrinology 161/4 (1. Oktober 2009): 575– 82, doi:10.1530/eje-09-0432.
118 Meng-Hsing Wu und Ming-Wei Lin, »The Role of Vitamin D in Polycystic Ovary Syndrome«, Indian Journal of Medical Research 142/3 (September 2015): 238, doi:10.4103/0971-5916.166527.
119 »Vitamin D Fact Sheet for Health Professionals«, NIH Office of Dietary Supplements, 11. Februar 2016, https://ods.od.nih.gov/factsheets/Vitamin-D-HealthProfessional/; Katherine Zeratsky, »Mayo Clinic Q and A: How Much Vitamin D Do I Need?« Mayo Clinic, 5. Juni 2015, https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-q-and-a-how-much-vitamin-d-do-i-need/.
120 Touraj Mahmoudi, »Genetic Variation in the Vitamin D Receptor and Polycystic Ovary Syndrome Risk«, Fertility and Sterility 92/4 (Oktober 2009): 1381–83, doi:10.1016/j.fertnstert.2009.05.002.
121 Y. Zhang et al., »Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1«, Journal of Immunology 188/5 (1. März 2012): 2127–35, doi:10.4049/jimmunol.1102412.
122 »Researchers Discover How Vitamin D Inhibits Inflammation«, National Jewish Health, 23. Februar 2012, https://www.nationaljewish.org/about/news/press-releases/2012/vitdmechanism.
123 M. Palmery et al., »Oral Contraceptives and Changes in Nutritional Requirements«, European Review for Medical and Pharmacological Sciences 17/13 (Juli 2013): 1804–13, https://www.ncbi.nlm.nih.gov/pubmed/23852908; Federico Lussana et al., »Blood Levels of Homocysteine, Folate, Vitamin B6 and B12 in Women Using Oral Contraceptives Compared to Non-users«, Thrombosis Research 112/1–2 (2003): 37–41, doi:10.1016/j.thromres.2003.11.007; Jennifer McArthur et al., »Biological Variability and Impact of Oral Contraceptives on Vitamins B6, B12 and Folate Status in Women of Reproductive Age«, Nutrients 5/9 (16. September 2013): 3634–45, doi:10.3390/nu5093634.
124 Federico Lussana et al., »Blood Levels of Homocysteine, Folate, Vitamin B6 and B12 in Women Using Oral Contraceptives Compared to Non-users«, Thrombosis Research 112/1–2 (2003): 37–41, doi:10.1016/j.thromres.2003.11.007.
125 M. Palmery, A. Saraceno, A. Vaiarelli und G. Carlomagno, »Oral Contraceptives and Changes in Nutritional Requirements«, European Review for Medical Pharmacological Sciences 17/13 (Juli 2013): 1804–813, https://www.ncbi.nlm.nih.gov/pubmed/23852908.
126 David S. H. Bell, »Metformin-Induced Vitamin B12 Deficiency Presenting as a Peripheral Neuropathy«, Southern Medical Journal 103/3 (3. Mai 2010): 265–67, doi:10.1097/smj.0b013e3181ce0e4d.
127 Faranak Sharifi et al., »Serum Magnesium Concentrations in Polycystic Ovary Syndrome and Its Association with Insulin Resistance«, Gynecological Endocrinology 28/1 (23. Juni 2011): 7–11, doi:10.3109/09513590.2011.579663.
128 Beatrice A. Golomb, »Association Between More Frequent Chocolate Consumption and Lower Body Mass Index«, Archives of Internal Medicine 172/6 (26. März 2012): 519, doi:10.1001/archinternmed.2011.2100.
129 D. Mastroiacovo et al., »Cocoa Flavanol Consumption Improves Cognitive Function, Blood Pressure Control, and Metabolic Profile in Elderly Subjects: The Cocoa, Cognition, and Aging (CoCoA) Study—A Randomized Controlled Trial«, American Journal of Clinical Nutrition 101/3 (17. Dezember 2014): 538–48, doi:10.3945/ajcn.114.092189.
130 Francois-Pierre J. Martin et al., »Metabolic Effects of Dark Chocolate Consumption on Energy, Gut Microbiota, and Stress-Related Metabolism in Free-Living Subjects«, Journal of Proteome Research 8/12 (Dezember 2009): 5568–79, doi:10.1021/pr900607v.
131 Davide Grassi et al., »Short-Term Administration of Dark Chocolate Is Followed by a Significant Increase in Insulin Sensitivity and a Decrease in Blood Pressure in Healthy Persons«, American Journal of Clinical Nutrition 81/3 (März 2005): 611–14, http://ajcn.nutrition.org/content/81/3/611.abstract.
132 Jia-Yi Dong et al., »Chocolate Consumption and Risk of Stroke Among Men And Women: A Large Population-Based, Prospective Cohort Study«, Atherosclerosis 260 (Mai 2017): 8–12, doi:10.1016/j.atherosclerosis.2017.03.004.
133 Bulent O. Yildiz et al., »Stability of Adrenocortical Steroidogenesis over Time in Healthy Women and Women with Polycystic Ovary Syndrome«, Journal of Clinical Endocrinology & Metabolism 89/11 (1. November 2004): 5558–62, doi:10.1210/jc.2004-0934.
134 Stephen H. Boutcher, »High-Intensity Intermittent Exercise and Fat Loss«, Journal of Obesity 2011 (24. November 2010): 1–10, doi:10.1155/2011/868305.
135 Ram Nidhi et al., »Effect of a Yoga Program on Glucose Metabolism and Blood Lipid Levels in Adolescent Girls with Polycystic Ovary Syndrome«, International Journal of Gynecology & Obstetrics 118/1 (14. April 2012): 37–41, doi:10.1016/j.ijgo.2012.01.027.
136 »Sleep and Disease Risk«, Healthy Sleep, Harvard Medical School, 18. Dezember 2007, http://healthysleep.med.harvard.edu/healthy/matters/consequences/sleep-and-disease-risk.
137 Esra Tasali, Eve Van Cauter und David A. Ehrmann, »Relationships Between Sleep Disordered Breathing and Glucose Metabolism in Polycystic Ovary Syndrome«, Journal of Clinical Endocrinology & Metabolism 91/1 (1. Januar 2006): 36–42, doi:10.1210/jc.2005-1084.
138 Joao Ricardo Araujo, Fatima Martel und Elisa Keating, »Exposure to Non-nutritive Sweeteners During Pregnancy and Lactation: Impact in Programming of Metabolic Diseases in the Progeny Later in Life«, Reproductive Toxicology 49 (November 2014): 196–201, doi:10.1016/j.reprotox.2014.09.007.
139 Edwin J. Routledge et al., »Some Alkyl Hydroxy Benzoate Preservatives (Parabens) Are Estrogenic«, Toxicology and Applied Pharmacology 153/1 (November 1998): 12–19, doi:10.1006/taap.1998.8544.
140 John D. Stokes und Charles L. Scudder, »The Effect of Butylated Hydroxyanisole and Butylated Hydroxytoluene on Behavioral Development of Mice«, Developmental Psychobiology 7/4 (Juli 1974): 343–50, doi:10.1002/dev.420070411.
141 »Sodium Benzoate/Sodium Phenylacetate Side Effects in Detail«, Drugs.com, aufgerufen am 26. Oktober 2017, https://www.drugs.com/sfx/sodium-benzoate-sodium-phenylacetate-side-effects.html.
142 R. S. Lanigan und T. A. Yamarik, »Final Report on the Safety Assessment of BHT«, International Journal of Toxicology 21/2 suppl (2002): 19–94, doi:10.1080/10915810290096513.
143 »14th Report on Carcinogens«, National Institute of Environmental Health Sciences, 3. November 2016, https://ntp.niehs.nih.gov/pubhealth/roc/index-1.html.
144 Brett Israel, »Brominated Battle: Soda Chemical Has Cloudy Health History«, Scientific American, 12. Dezember 2011, https://www.scientificamerican.com/article/soda-chemical-cloudy-health-history/.
145 Renata Micha, Sarah K. Wallace und Dariush Mozaffarian, »Red and Processed Meat Consumption and Risk of Incident Coronary Heart Disease, Stroke, and Diabetes: A Systematic Review and Meta-Analysis«, Circulation 121/21 (1. Juni 2010): 2271–83, doi:10.1161/CIRCULATIONAHA.109.924977; Katherine Zeratsky, »The Unhealthy Preservative Hiding in Processed Meats«, Mayo Clinic, 10. April 2015, http://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/expert-answers/sodium-nitrate/faq-20057848.
146 »IARC Monographs Evaluate Consumption of Red Meat and Processed Meat«, International Agency for Research on Cancer, World Health Organization, 26. Oktober 2015, https://www.iarc.fr/en/media-centre/pr/2015/pdfs/pr240_E.pdf.
147 Christopher Gavigan, »Food Dyes: Red Does Not Mean GO«, Huffington Post, 23. September 2013, http://www.huffingtonpost.com/christopher-gavigan/food-dye_b_3792860.html.
148 »CFR-Code of Federal Regulations Title 21«, US Food & Drug Administration, 1. April 2016, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFR-Part=73&showFR=1.
149 Mel Robbins, »The 5 Second Rule«, 2. April 2016, http://melrobbins.com/the-5-second-rule/.
150 K. Chaiyasit, W. Khovidhunkit und S. Wittayalertpanya, »Pharmacokinetic and the Effect of Capsaicin in Capsicum frutescens on Decreasing Plasma Glucose Level«, Journal of the Medical Association of Thailand 92/1 (Januar 2009): 108–13, https://www.ncbi.nlm.nih.gov/pubmed/19260251.
151 Masayuki Saito and Takeshi Yoneshiro, »Capsinoids and Related Food Ingredients Activating Brown Fat Thermogenesis and Reducing Body Fat in Humans«, Current Opinion in Lipidology 24/1 (Februar 2013): 71–77, doi:10.1097/mol.0b013e32835a4f40; Stephen Whiting, Emma Derbyshire und B. K. Tiwari, »Capsaicinoids and Capsinoids. A Potential Role for Weight Management? A Systematic Review of the Evidence«, Appetite 59/2 (2012): 341–48, doi:10.1016/j.appet.2012.05.015.
152 Sepide Mahluji et al., »Effects of Ginger (Zingiber officinale) on Plasma Glucose Level, HbA1c and Insulin Sensitivity in Type 2 Diabetic Patients«, International Journal of Food Sciences and Nutrition 64/6 (September 2013): 682–86, doi:10.3109/09637486.2013.7752 23; Yiming Li et al., »Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review«, Evidence-Based Complementary and Alternative Medicine 2012 (2012): 1–10, doi:10.1155/2012/516870.
153 C. S. Johnston, C. M. Kim und A. J. Buller, »Vinegar Improves Insulin Sensitivity to a High-Carbohydrate Meal in Subjects with Insulin Resistance or Type 2 Diabetes«, Diabetes Care 27/1 (Januar 2004): 281–82, doi:10.2337/diacare.27.1.281.
154 Ahmed Sahib, »Antidiabetic and Antioxidant Effect of Cinnamon in Poorly Controlled Type-2 Diabetic Iraqi Patients: A Randomized, Placebo-Controlled Clinical Trial«, Journal of Intercultural Ethnopharmacology 5/2 (2016): 108, doi:10.5455/jice.20160217044511.
155 Nita Chainani-Wu, »Safety and Anti-Inflammatory Activity of Curcumin: A Component of Tumeric (Curcuma longa)«, Journal of Alternative and Complementary Medicine 9/1 (Februar 2003): 161–68, doi:10.1089/107555303321223035.
156 Omotayo O. Erejuwa, Siti A. Sulaiman und Mohd S. Ab Wahab, »Honey—A Novel Antidiabetic Agent«, International Journal of Biological Sciences 8/6 (7. Juli 2012): 913–34, doi:10.7150/ijbs.3697.
157 Ron Fessenden, »The Honey Revolution«, Living Honey, aufgerufen am 26. Oktober 2017, http://www.livinghoney.biz/the-honey-revolution.html.
158 Olabisi Oduwole et al., »Honey for Acute Cough in Children«, Evidence-Based Child Health: A Cochrane Review Journal 9/2 (14. März 2014): 401–44, doi:10.1002/ebch.1970.
159 P. Lusby, A. Coombes und J. M. Wilkinson, »Honey: A Potent Agent for Wound Healing?« Journal of Wound, Ostomy, and Continence Nursing 29/6 (November 2002): 295–300, doi:10.1067/mjw.2002.129073.
160 A. Franke et al., »Postprandial Walking but Not Consumption of Alcoholic Digestifs or Espresso Accelerates Gastric Emptying in Healthy Volunteers«, Journal of Gastrointestinal and Liver Diseases 17/1 (März 2008): 27–31, https://www.ncbi.nlm.nih.gov/pubmed/18392240; Sheri R. Colberg et al., »Postprandial Walking Is Better for Lowering the Glycemic Effect of Dinner Than Pre-Dinner Exercise in Type 2 Diabetic Individuals«, Journal of the American Medical Directors Association 10/6 (Juli 2009): 394–97, doi:10.1016/j.jamda.2009.03.015; L. Dipietro et al., »Three 15-Min Bouts of Moderate Postmeal Walking Significantly Improves 24-h Glycemic Control in Older People at Risk for Impaired Glucose Tolerance«, Diabetes Care 36/10 (Oktober 2013): 3262–68, doi:10.2337/dc13–0084.
161 Anne-Marie Chang et al., »Evening Use of Light-Emitting eReaders Negatively Affects Sleep, Circadian Timing, and Next-Morning Alertness«, PNAS, 22. Dezember 2014, doi:10.1073/pnas.1418490112.
162 Tommi Moykkynen et al., »Magnesium Potentiation of the Function of Native and Recombinant GABA(A) Receptors«, Neuroreport 12/10 (Juli 2001): 2175–79, doi:10.1097/00001756-200107200-00026.
163 S. W. Golf et al., »Plasma Aldosterone, Cortisol and Electrolyte Concentrations in Physical Exercise After Magnesium Supplementation«, Journal of Clinical Chemistry and Clinical Biochemistry 22/11 (November 1984): 717–21, doi:10.1515/cclm.1984.22.11.717.
164 Peir Hossein Koulivand, Maryam Khaleghi Ghadiri und Ali Gorji, »Lavender and the Nervous System«, Evidence-Based Complementary and Alternative Medicine, 14. März 2013, doi:10.1155/2013/681304.
165 Michelle Navarra et al., »Citrus Bergamia Essential Oil: From Basic Research to Clinical Application«, Frontiers in Pharmacology, 2. März 2015, doi:10.3389/fphar.2015.00036.
166 Tapanee Hongratanaworakit und Gerhard Buchbauer, »Relaxing Effect of Ylang Oil on Humans After Transdermal Absorption«, Phytotherapy Research 20/9 (20. September 2006): 758–63, doi:10.1002/ptr.1950.
167 Kyung-Bok Lee, Eun Cho und Young-Sook Kang, »Changes in 5-Hydroxytryptamine and Cortisol Plasma Levels in Menopausal Women After Inhalation of Clary Sage Oil«, Phytotherapy Research 28/12 (November 2014): 1897, doi:10.1002/ptr.5268.
168 »Reading ‘Can Help Reduce Stress,’« The Telegraph, 30. März 2009, http://www.telegraph.co.uk/news/health/news/5070874/Reading-can-help-reduce-stress.html.
169 Anantha Lakkakula et al., »Repeated Taste Exposure Increases Liking for Vegetables by Low-Income Elementary School Children«, Appetite 55/2 (Oktober 2010): 226–31, doi:10.1016/j.appet.2010.06.003.
170 INFJ type, Sixteen Personalities test, https://www.16personalities.com/infj-strengths-and-weaknesses.
171Psychopharmacology